Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

May 17, 2022 4:05pm EDT

Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

May 17, 2022 7:00am EDT

Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

May 16, 2022 7:05am EDT

Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

Apr 25, 2022 4:05pm EDT

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

Apr 25, 2022 7:00am EDT

Beyond Air® to Participate in Three Upcoming Medical Conferences

Apr 18, 2022 7:00am EDT

Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

Apr 11, 2022 7:00am EDT

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

Mar 08, 2022 4:35pm EST

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022

Feb 10, 2022 4:05pm EST

Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022

Feb 08, 2022 8:00am EST